Replay of: Live Webcast of Resective Surgery for Refractory Epilepsy, A Highly Effective Surgical Treatment of Epilepsy from Memorial Hermann Texas Medical Center
First Seen Live Webcast: Tuesday, December 20th, 2005, at 5:30 pm CT (23:30 UTC)
View webcast with RealPlayer. Click here to download a free copy.
To view this program, you may need to disable pop-up blockers.
Join the Discussion! Memorial Hermann Texas Medical Center is sponsoring a forum with Dr. Nitin Tandon, Dr. Jeremy Slater and Dr. Dennis Vollmer answering your questions on Resective Surgery for Refractory Epilepsy.
Click here to join the discussion
While the majority of patients with epilepsy are managed well with medications, a significant number of patients – approximately 25 percent – do not respond well to pharmacological therapy. For many of these patients with pharmaco-resistant epilepsy, surgery may offer a positive outcome.
The surgery will be performed by Nitin Tandon, M.D., assistant professor of neurosurgery at the University of Texas Medical School at Houston.
Resective surgery for epilepsy targets a specific, localized part of the brain, where the seizures are thought to originate. Though the origin of seizures may be within the frontal, parietal or occipital lobes, most typically, medically refractory seizures originate deep within the temporal lobe. Patients with such seizures can be well treated by a temporal lobectomy - a resective surgery in which scarring deep in the temporal lobe, in a part called the hippocampus, is removed.
Following surgery, over half of patients remain seizure free, and a total of 85 percent report significantly decreased number and severity of seizures.
Dennis Vollmer, M.D., chief of neurosurgery at Memorial Hermann and chairman of neurosurgery at The University of Texas Medical School at Houston served as moderator of the live.
The webcast and streaming videos on this site and OR-Live are produced in Real to provide an enhanced viewer experience. Click here to download the free copy of RealPlayer.